Trial Profile
Effect of Tailored Use of Tirofiban in Patients With Non-ST-elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 19 Apr 2017 New trial record